Uses of myostatin antagonists

Details for Australian Patent Application No. 2006321906 (hide)

Owner Amgen Inc.

Inventors Lu, John Zhao-Nian; Depaoli, Alexander; Han, Hq; Wang, Jin Lin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006321906

PCT Pub. Number WO2007/067616

Priority 60/742,731 06.12.05 US

Filing date 6 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 9 September 2010

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/067616 Priority application(s): WO2007/067616

9 September 2010 Application Accepted

  Published as AU-B-2006321906

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006321907-Use of a CB1 antagonist for treating negative symptoms of schizophrenia

2006321905-Thiadiazole derivatives as antidiabetic agents